USPTO Slams Lundbeck's PTSD Drug Patent Term Suit
IP Law 360
FEBRUARY 2, 2024
The U.S. Patent and Trademark Office is going for an early win in Virginia federal court where Danish drugmaker H. Lundbeck A/S is seeking to extend the life of a patent for a PTSD drug by three months, calling the case straightforward.
Let's personalize your content